BioSource, Institute in Accord on Research Tools

BioSource International in Camarillo has reached an agreement with Childrens Hospital Los Angeles Research Institute for the commercial rights to all research tools developed at the institute.

The nonprofit institute is a research center specializing in AIDS, immunology, cancer and gene therapy. It has more than 250 postdoctoral fellows and graduate students, as well as 250 tenured faculty members.

Under terms of the agreement, BioSource will have rights of first refusal for all research tools developed at the institute. These tools will be used by BioSource in development of its products.

In addition, BioSource will become the preferred vendor to the institute of all immunological, cellular biological and molecular biological products. BioSource will provide the institute with an annual research grant of $100,000, as well as royalties on the sale of any licensed products.

A researcher from the institute will be appointed to BioSource’s Scientific Advisory Board.

“I am very pleased that we are able to assist in the funding and provision of research products to help diagnose, treat and prevent pediatric diseases and promote child health,” said James A. Chamberlain, BioSource president and chief executive officer. “Through collaboration with this prestigious scientific center, we have obtained an excellent resource enabling us to leverage our immunological, cell biological and molecular biological product line.”

BioSource develops and manufactures test kits used in biomedical research.